Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000050089 | SCV001589944 | pathogenic | Cohen syndrome | 2021-08-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 56676). This variant is also known as c.5730_5731insA. This premature translational stop signal has been observed in individual(s) with Cohen syndrome (PMID: 15141358). This variant is present in population databases (rs757201708, ExAC 0.02%). This sequence change creates a premature translational stop signal (p.Ile1913Asnfs*7) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000050089 | SCV000082498 | probable-pathogenic | Cohen syndrome | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |